Did Anthropic Suck the Air From Palantir’s Commercial Contract Tailwinds?

3 weeks ago 19

Rich Duprey

Mon, May 4, 2026 astatine 11:45 AM CDT 3 min read

Quick Read

  • Palantir (PLTR) posted Q1 2025 U.S. commercialized gross of $507M up 137% YoY with guidance for astatine slightest 115% U.S. commercialized maturation successful 2026.

  • Anthropic’s endeavor Claude rollout is pressuring Palantir’s bundle income arsenic the marketplace reshuffles AI vendor selection.

  • The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and Palantir wasn't 1 of them. Get them present FREE.

Palantir Technologies (NASDAQ: PLTR) reports Q1 2026 results aft the adjacent today. Management guided astatine slightest 115% U.S. commercialized maturation for the twelvemonth conscionable arsenic Anthropic's endeavor AI propulsion reshaped bundle buying. I'll beryllium watching whether commercialized momentum held.

Commercial Acceleration Meets a New Competitor

Last 4th Palantir delivered $1.41B successful revenue, up 70% YoY, with U.S. commercialized gross of $507 million, up 137% year-over-year and 28% sequentially. Total declaration worth closed reached $4.262B, up 138%, and CEO Alex Karp called the steadfast "an n of 1" with a Rule of 40 people of 127.

Then came what investors dubbed the "SaaS-pocalypse", arsenic Anthropic's endeavor Claude rollouts earlier this twelvemonth forced buyers to rethink bundle stacks. Shares are down 18.95% year-to-date into today's report, adjacent aft a 23.98% one-year gain. The question is whether commercialized request kept compounding done that competitory shock.

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and Palantir wasn't 1 of them. Get them present FREE.

Consensus and Guidance Snapshot

Metric

Q1 2026 Guide

YoY Comparison

Revenue

$1.532B-$1.536B

~73% YoY vs Q1 2025 $883.86M

Adj. Operating Income

$870M-$874M

n/a

FY 2026 Revenue

$7.182B-$7.198B

~61% YoY vs $4.475B FY 2025

FY 2026 U.S. Commercial

>$3.144B

at slightest 115% YoY

FY 2025 Reported EPS

$0.75

n/a

Commercial Velocity vs. Anthropic Pressure

Watch the U.S. commercialized enactment supra all. The 2025 ramp tells the story: $255M successful Q1, $306M successful Q2, $397M successful Q3, and $507M successful Q4. I'll beryllium watching whether Q1 2026 holds that $507M basal oregon kicks higher. A level oregon sequentially down fig would beryllium the archetypal hard information that Anthropic and frontier exemplary labs are siphoning endeavor budgets.

You should besides absorption connected incremental margins. Q4 GAAP operating borderline landed astatine 41%, and the adjusted operating borderline deed 57% with nett dollar retention of 139%. If U.S. commercialized keeps printing triple-digit maturation and margins grow again, the commoditization thesis gets reinforced.

Three different inputs matter. First, caller TCV bookings aft a grounds $1.3 cardinal U.S. commercialized TCV successful Q4. Second, lawsuit count, which grew 49% YoY to 571 U.S. commercialized customers. Third, immoderate nonstop absorption commentary connected Claude oregon competing exemplary providers. Recent wins similar the three-year Cleveland-Cliffs AI concern announced April 29 springiness Karp ammunition to reason AIP is widening its lane.

Read Entire Article